μμ€νΈλΌλμ¬ μνΌμ€λ€μ΄νΈ
μμ€νΈλΌλμ¬ μνΌμ€λ€μ΄νΈλ μ§μν μ²μ° μμ€νΈλ‘κ² μμ€ν λ₯΄ μ λ체μ λλ€. κ³Όκ±°μλ μλλ¬Όμ λνμ½(κ΅λ―Έ ν νΌμ)μΌλ‘ λ리 μ¬μ©λμμΌλ, **μΉλͺ μ μΈ κ³¨μ μ΅μ **(μ¬μλΆλμ± λΉν) λ° **μκΆμΆλμ¦**μ μ λ°ν μνμ΄ λμ νμ¬ λλΆλΆμ μμ λ²μνμλ€μ κ°μ κ³ μμ΄μκ² μ¬μ©μ κΆμ₯νμ§ μμ΅λλ€. λ μμ νκ³ ν¨κ³Όμ μΈ λμμ΄ μ νΈλ©λλ€. > **μμ μ£Όμμ¬ν**: FDAλ μ΄ μ½λ¬Όμ μμ© λλ¬Όμ μ¬μ©νλ κ²μ μ격ν κΈμ§νκ³ μμΌλ©°, ν΄λΉ λλ¬Όμ μν ν¬μ¬λ μ‘°μ λ λΆλ²μ λλ€.
μμ© κΈ°μ : Estradiol is the most active endogenous estrogen. It diffuses across the cell membrane and binds to specific intracellular **estrogen receptors (ERΞ± and ERΞ²)**. The receptor-hormone complex translocates to the nucleus β binds to **estrogen response elements (EREs)** on DNA β modulates gene transcription. **Key systemic effects include:** * **Reproductive:** Stimulates normal growth and development of female sex organs, increases cervical mucosal secretions, thickens vaginal mucosa, and induces endometrial proliferation and uterine tone. * **Skeletal:** Increases calcium deposition, accelerates epiphyseal closure, and promotes bone formation. * **Endocrine:** Modulates pituitary gonadotropin release, which can inhibit lactation, ovulation, and androgen secretion.
λλ¬Ό μ’ λ³ μ©λ
- Pregnancy avoidance after mismating Β· 250 micrograms/kg (0.25 mg/kg) IM once 6 days after coitus; or 0.25 mg/cat IM at 40 hours after coitus Β· IM Β· once Β· Rarely used for this indication today as there are safer, more effective treatments.
- Any Β· Illegal Β· The FDA has stated that the use of ECP in food-producing animals is illegal.
- To enhance estrus behavior and receptivity in ovariectomized mares Β· 5-10 mg (total dose) IM once Β· IM Β· once
- Treatment of mares with estrogen-responsive incontinence Β· 4-10 micrograms/kg estradiol cypionate IM daily for three days and then every other day Β· IM Β· daily then q48h Β· 3 days then ongoing Β· Some mares will improve, but does not 'cure'.
- Pregnancy avoidance after mismating Β· 44 micrograms/kg (0.044 mg/kg) IM once; during day 4 estrus to day 2 of diestrus Β· IM Β· once Β· Rarely used for this indication today as there are safer, more effective treatments. Toxic at >=100 micrograms/kg.
μ©λμ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μ°Έκ³ μλ£μ λλ€. νμ μ΅μ λΌλ²¨κ³Ό κ°λ³ νμμ λν΄ νμΈνμμμ€.
ν¬μ¬ κ²½λ‘
κΈκΈ°
- Pregnancy (teratogenic and causes fetal bone marrow depression)
- Food-producing animals (illegal per FDA)
- Ferrets (highly susceptible to severe bone marrow toxicity)
- Estrogen-responsive incontinence in small animals (safer alternatives like DES or estriol should be used)
μ΄μλ°μ
- Bone marrow toxicity (thrombocytopenia, leukopenia, fatal aplastic anemia)
- Cystic endometrial hyperplasia
- Pyometra
- Mammary neoplasia
- Feminization (in males)
- Prolonged estrus (in females)
- Genital irritation (cattle)
- Decreased milk flow (cattle)
- Follicular cysts (cattle)
μ½λ¬Ό μνΈμμ©
- Azole Antifungals (fluconazole, itraconazole, ketoconazole) Β· May increase estrogen levels due to CYP450 enzyme inhibition.
- Corticosteroids Β· Enhanced glucocorticoid effects; estrogens may alter protein binding or decrease metabolism of corticosteroids.
- Macrolide Antibiotics (erythromycin, clarithromycin) Β· May increase estrogen levels.
- Phenobarbital Β· May decrease estrogen activity via hepatic enzyme induction.
- Rifampin Β· May decrease estrogen activity via hepatic enzyme induction.
- St. John's Wort Β· May decrease estrogen activity.
- Warfarin Β· Oral anticoagulant activity may be decreased; dosage adjustments may be necessary.
λͺ¨λν°λ§
- Packed Cell Volumes (PCV)
- White blood cell counts (CBC)
- Platelet counts (Baseline, one month after therapy, and repeated two months after cessation if abnormal)
- Liver function tests
κ³Όμ©λ
Acute overdosage reports in veterinary patients are rare, but chronic or high-dose exposure leads to severe adverse effects. **Overdose manifestations:** * **Small Animals:** Severe bone marrow depression (thrombocytopenia, leukopenia, aplastic anemia), cystic endometrial hyperplasia, and pyometra. * **Cattle:** Prolonged estrus, genital irritation, decreased milk flow, precocious development, and follicular cysts. Treatment is largely supportive. If bone marrow suppression occurs, aggressive supportive care (transfusions, broad-spectrum antibiotics) is required, though prognosis for aplastic anemia is poor.
VetSheet μ½λ¬Ό λ νΌλ°μ€λ λ©΄ν μμ μ λ¬Έκ°λ₯Ό μν μμ μμ¬κ²°μ 보쑰 λꡬμ΄λ©°, μ λ¬Έμ νλ¨μ΄λ μ μ‘°μ¬μ μ΅μ λΌλ²¨μ λμ νμ§ μμ΅λλ€.